ProCE Banner Series

Contemporary HIV Treatment and Prevention 2024: Implementing LA ART in Clinical Practice

Join us to learn expert insights into the practical steps required to realize the potential of long-acting ART and long-acting PrEP on the part of both patients and healthcare professionals, drawing on real-world experiences and insights from implementation studies.

  ACPE
  | AMA
  | ANCC
Who Should Attend

This program is intended for physicians, registered nurses, nurse practitioners, physician associates, pharmacists, and other healthcare professionals who provide care for people living with or at risk of HIV infection.

All Events

Contemporary HIV Treatment and Prevention 2024: Implementing LA ART in Clinical Practice

Upcoming Events

September

24

2024

6:00 PM - 8:00 PM Eastern Time (ET)

In-person

Seasons 52, 245 Summit Blvd, Birmingham, Alabama 35243

September

26

2024

6:00 PM - 8:00 PM Central Time (CT)

In-person

Char Restaurant, 431 S. Highland Street #120, Memphis, Tennessee 38111

October

03

2024

6:00 PM - 8:00 PM Eastern Time (ET)

In-person

Ruth Chris Steak House, Hilton Columbia Center, 924 Senate Street, Columbia, South Carolina 29201

Past Events

August

29

2024

6:00 PM - 8:00 PM Central Time (CT)

In-person

Maggiano's Little Italy Northpark, 205 NorthPark Center, Dallas, Texas 75225

Faculty

ProCE Banner Faculty
Roger Bedimo, MD, MS, FACP

Professor of Medicine
Interim Director, Office of Global Health
UT Southwestern Medical Center
Chief, Infectious Diseases Section
VA North Texas Health Care System
Dallas, Texas

ProCE Banner Faculty
Gregory Huhn, MD, MPHTM

Interim Chief, Division of Infectious Diseases
Senior Director of HIV Services
Cook County HIV Integrated Programs
Interim Medical Director, The RMR CORE Center
Professor, Division of Infectious Diseases
Rush University Medical Center
Chicago, Illinois

ProCE Banner Faculty
Aadia I. Rana, MD

Professor of Medicine
Division of Infectious Diseases
University of Alabama at Birmingham Heersink School of Medicine
Birmingham, Alabama

ProCE Banner Faculty
David A. Wohl, MD

Professor of Medicine
School of Medicine
Site Leader, Global Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Topics

HIV

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve learners’ competence in implementing optimal HIV treatment and prevention strategies through the appropriate use of contemporary antiretroviral regimens.

Target Audience
This program is intended for physicians, registered nurses, nurse practitioners, physician associates, pharmacists, and other healthcare professionals who provide care for people living with or at risk of HIV infection. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Integrate strategies to proactively consider patient candidacy for long-acting ART, administer it appropriately, support patient adherence to dosing visits, and minimize barriers to uptake and adverse events
  • Describe the considerations for initiation and use of long-acting injectable ART for PrEP
  • Select an appropriate initial ART regimen for a patient experiencing seroconversion who was previously receiving long-acting PrEP

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.5 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-24-179-L02-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC, in partnership with HealthHIV

Supported by an educational grant from ViiV Healthcare.